GIACHE', VALENTINO
 Distribuzione geografica
Continente #
NA - Nord America 974
EU - Europa 625
AS - Asia 195
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.798
Nazione #
US - Stati Uniti d'America 965
SE - Svezia 279
IE - Irlanda 164
CN - Cina 64
IT - Italia 49
HK - Hong Kong 47
TR - Turchia 43
DE - Germania 40
FI - Finlandia 33
GB - Regno Unito 23
JO - Giordania 23
BE - Belgio 12
CA - Canada 8
UA - Ucraina 8
IN - India 7
SG - Singapore 7
AT - Austria 5
FR - Francia 4
JP - Giappone 4
CH - Svizzera 3
RU - Federazione Russa 3
DZ - Algeria 2
NL - Olanda 2
CR - Costa Rica 1
EU - Europa 1
NZ - Nuova Zelanda 1
Totale 1.798
Città #
Chandler 216
Dublin 162
Jacksonville 82
Fairfield 62
Ann Arbor 59
Ashburn 44
Cambridge 39
Izmir 38
Dearborn 35
Buffalo 33
Princeton 33
Wilmington 32
Boston 31
Beijing 30
Seattle 29
Woodbridge 26
Boardman 24
Hong Kong 24
Houston 16
Kent 16
Brussels 12
Shanghai 12
New York 10
Medford 9
Toronto 8
Andover 6
Venice 6
San Diego 5
Singapore 5
Vienna 5
Norwalk 4
Bern 3
Hillsboro 3
Kunming 3
Pune 3
Algiers 2
Altavilla Vicentina 2
Aversa 2
Cattolica 2
Cellino San Marco 2
Chengdu 2
Grevenbroich 2
Guangzhou 2
Milan 2
Naples 2
Pollenza 2
Pomezia 2
Ravenna 2
Rome 2
Verona 2
West Jordan 2
Zhengzhou 2
Athlone 1
Baotou 1
Carlow 1
Carosino 1
Changchun 1
Chongqing 1
Costa Mesa 1
Fuzhou 1
Haibowan 1
Harbin 1
Hefei 1
Jackson 1
La Fortuna 1
Lanciano 1
Lawrence 1
Liverpool 1
Los Angeles 1
Miami 1
Monte San Savino 1
Nanchang 1
Nanjing 1
Orbassano 1
Palo Alto 1
Rowlett 1
Rozzano 1
Saint Petersburg 1
Salerno 1
Sessa Aurunca 1
Shaoxing 1
Te Awamutu 1
Turin 1
Washington 1
Westbrook 1
Totale 1.192
Nome #
Genetic screening for pheochromocytoma: should SDHC gene analysis be included? 90
Evidence for different site-related genetic mechanisms in the pathogenesis of sporadic colorectal cancer. 83
Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and/or functional or non-functional paragangliomas. 78
Functional study in a yeast model of a novel succinate-dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor. 77
Analisi dell' attivita' proliferativa e del suo significato prognostico nei tumori superficiali della vescica. 76
Heterogeneity in growth of human solid tumours. 75
K-ras in colorectal cancer: mutation status and clinicopathologic correlation. 74
K-ras mutations in human sporadic colorectal carcinomas. 73
C-myc and c-fos expression and K-ras muttion in human colorectal carcinoma. 69
DNA ploidy, cell proliferation and genetic alterations in colorectal cancer: correlation with clinicopathological features. 68
La differenziazione cellulare dopo irradiazione : il modello intestino tenue. 62
Effect of multiple daily fractionation of the dose in the small intestine of rats. 62
Modification of circadian dependence of intestinal maltase after irradiation. 62
Aspetti del danno intestinale dopo differenti modalita' di somministrazione della dose. 58
Chromosome 17 deletion in colorectal carcinomas. 58
Biochemical changes in the small intestine after irradiation at different times of the day. 58
Analysis of the presence and physical state of different human papilloma virus DNA in cervical intraepithelial neoplasms. 58
Acute intestinal damage in the small intestine. Effect of multiple daily fractionation of the dose in the small intestine of rats. 52
Proliferative characterization of bladder transitional cell carcinoma. 52
Human solid tumors: variability of proliferative activity within the tumor. 46
Multivariate analysis of prognostic value of 3H-thymidine labeling index (TLI) in laryngeal carcinoma. 46
Proliferative activity of gastric mucosa: modifications induced by Helicobacter pylori. 44
Micromethod for the quantitation of DNA. 44
Genetic nature of sporadic colorectal carcinoma. Evidence for different site-related tumorigenic mechanisms. 42
The effect of different multiple daily fractionation on the small intestine. 39
Biochemical studies on the small intestine after multiple daily fractionation. 39
Il carcinoma colorettale: valore prognostico dei parametri istopatologici, grado di ploidia, attività proliferativa e mutazioni dei geni p53 e K-ras. 39
Biochemical modifications in spleen and small intestine after 3 Gy. 36
Thymidine labeling index as a prognostically significant parameter in carcinoma of the larynx. 34
P53 mutation, mRNA expression and 17p allelic loss in colorectal carcinoma. 30
Variations in proliferative activity of the gastric stump in relation to enterobiliary reflux. 29
Proliferative activity in intestinal mucosa of patients with colon adenocarcinoma. 28
Tp53 mutation in primary colorectal cancer. 24
Totale 1.805
Categoria #
all - tutte 4.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201917 0 0 0 0 0 0 0 0 0 0 0 17
2019/2020216 14 9 1 12 13 29 50 37 12 21 17 1
2020/2021261 40 6 38 6 3 38 3 8 23 22 24 50
2021/2022206 23 31 0 12 10 2 2 10 5 4 63 44
2022/2023644 62 66 25 77 63 127 84 44 68 2 11 15
2023/2024244 20 20 32 8 21 57 4 40 4 2 24 12
Totale 1.805